Principal Investigator
Matthew Schlumbrecht
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230506
Clinical Trial Summary
A phase 1/1b dose escalation study of abemaciclib and olaparib for recurrent platinum- resistant ovarian cancer
Phase
Phase I
Funding Agency/Sponsor
National Cooperative Group
Disease
Gynecologic Cancer
Contact Information
Phone Number
305-243-2647